Author
Listed:
- Pawel K. Mazur
(Stanford University School of Medicine
Stanford University School of Medicine)
- Nicolas Reynoird
(Stanford University)
- Purvesh Khatri
(Institute for Immunity, Transplantation and Infection, Stanford University School of Medicine)
- Pascal W. T. C. Jansen
(University Medical Center Utrecht, 3508 AB Utrecht, The Netherlands)
- Alex W. Wilkinson
(Stanford University)
- Shichong Liu
(Perelman School of Medicine, University of Pennsylvania)
- Olena Barbash
(Cancer Epigenetics DPU, Oncology R&D, GlaxoSmithKline, Collegeville)
- Glenn S. Van Aller
(Cancer Epigenetics DPU, Oncology R&D, GlaxoSmithKline, Collegeville)
- Michael Huddleston
(Cancer Epigenetics DPU, Oncology R&D, GlaxoSmithKline, Collegeville)
- Dashyant Dhanak
(Cancer Epigenetics DPU, Oncology R&D, GlaxoSmithKline, Collegeville
Present addresses: Janssen Research and Development, 1400 McKean Road, Spring House, Pennsylvania 19477, USA (D.D.); Department of Molecular Biology, Faculty of Science, Radboud Institute for Molecular Life Sciences (RIMLS), Radboud University, 6525GA Nijmegen, The Netherlands (M.V.).)
- Peter J. Tummino
(Cancer Epigenetics DPU, Oncology R&D, GlaxoSmithKline, Collegeville)
- Ryan G. Kruger
(Cancer Epigenetics DPU, Oncology R&D, GlaxoSmithKline, Collegeville)
- Benjamin A. Garcia
(Perelman School of Medicine, University of Pennsylvania)
- Atul J. Butte
(Stanford University School of Medicine
Stanford University School of Medicine)
- Michiel Vermeulen
(University Medical Center Utrecht, 3508 AB Utrecht, The Netherlands
Present addresses: Janssen Research and Development, 1400 McKean Road, Spring House, Pennsylvania 19477, USA (D.D.); Department of Molecular Biology, Faculty of Science, Radboud Institute for Molecular Life Sciences (RIMLS), Radboud University, 6525GA Nijmegen, The Netherlands (M.V.).)
- Julien Sage
(Stanford University School of Medicine
Stanford University School of Medicine)
- Or Gozani
(Stanford University)
Abstract
SMYD3 is a methyltransferase overexpressed in several human tumours; here methylation of the MAP3K2 kinase by SMYD3 is shown to be critical for Ras-induced tumour development in mouse models and human tumour cells, showing an unexpected role for methylation in a kinase signalling pathway and revealing a candidate therapeutic target.
Suggested Citation
Pawel K. Mazur & Nicolas Reynoird & Purvesh Khatri & Pascal W. T. C. Jansen & Alex W. Wilkinson & Shichong Liu & Olena Barbash & Glenn S. Van Aller & Michael Huddleston & Dashyant Dhanak & Peter J. Tu, 2014.
"SMYD3 links lysine methylation of MAP3K2 to Ras-driven cancer,"
Nature, Nature, vol. 510(7504), pages 283-287, June.
Handle:
RePEc:nat:nature:v:510:y:2014:i:7504:d:10.1038_nature13320
DOI: 10.1038/nature13320
Download full text from publisher
As the access to this document is restricted, you may want to search for a different version of it.
Citations
Citations are extracted by the
CitEc Project, subscribe to its
RSS feed for this item.
Cited by:
- Bo Yu & Jun Su & Qiqi Shi & Qing Liu & Jun Ma & Guoqing Ru & Lei Zhang & Jian Zhang & Xichun Hu & Jianming Tang, 2022.
"KMT5A-methylated SNIP1 promotes triple-negative breast cancer metastasis by activating YAP signaling,"
Nature Communications, Nature, vol. 13(1), pages 1-18, December.
- Jamal B. Williams & Qing Cao & Wei Wang & Young-Ho Lee & Luye Qin & Ping Zhong & Yong Ren & Kaijie Ma & Zhen Yan, 2023.
"Inhibition of histone methyltransferase Smyd3 rescues NMDAR and cognitive deficits in a tauopathy mouse model,"
Nature Communications, Nature, vol. 14(1), pages 1-13, December.
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:nature:v:510:y:2014:i:7504:d:10.1038_nature13320. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.